We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Juno Therapeutics, Inc. (delisted) | NASDAQ:JUNO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 86.96 | 77.15 | 87.00 | 0 | 01:00:00 |
Delaware
(State or other jurisdiction
of incorporation)
|
001-36781
(Commission
File Number)
|
46-3656275
(IRS Employer
Identification No.)
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
.
|
•
|
Up to 21,535 shares will become eligible to vest based on the first approval by the U.S. Food & Drug Administration (the "FDA") of JCAR017 in any indication within certain designated timeframes (the "JCAR017 Milestone").
|
◦
|
50% of the shares that become eligible to vest upon the achievement of the JCAR017 Milestone will vest immediately upon such achievement.
|
◦
|
The remaining 50% of shares that become eligible to vest upon the achievement of the JCAR017 Milestone will vest on the one year anniversary of the date of such achievement.
|
•
|
Up to 14,358 shares will vest based upon the first approval by the FDA of JCARH125 in any indication within certain designated timeframes.
|
Item 9.01
|
Financial Statements and Exhibits
.
|
|
|
|
Exhibit
No. |
|
Description
|
|
|
|
10.1
|
|
By:
|
/s/ Hans E. Bishop
Hans E. Bishop |
|
|
|
Exhibit
No. |
|
Description
|
|
|
|
10.1
|
|
Form of Performance Restricted Stock Agreement under the 2014 Equity Incentive Plan
|
1 Year JUNO THERAPEUTICS, INC. Chart |
1 Month JUNO THERAPEUTICS, INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions